🔎 Trials Near Me

Почетна › Метастатски карцином › Тенеси

Kliničke studije za Метастатски карцином u državi Тенеси

74 studija za Метастатски карцином traži učesnike na lokacijama u državi Тенеси.

Gradovi u državi Тенеси

Zvanični tekst studije (na engleskom)

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

  • Clinical Study Site, Nashville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07335497

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Tennessee Oncology, Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06270706

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
  • Regional Cancer Center at Johnson City Medical Center, Johnson City
  • Ballad Health Cancer Care - Kingsport, Kingsport
  • и још 3
Тражи се учесникФаза 2
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

  • Sarah Cannon Research Institute-Nashville-48456, Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04886804

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • SCRI Oncology Partners, Nashville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07020221

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • West Cancer Center, Germantown
  • Sarah Cannon Research Institute, Nashville
  • Tennessee Oncology, Nashville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07562152

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

  • Sarah Cannon, Nashville
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT05384626

CREO - Microwave Ablation Feasibility Study

  • University of Tennessee Medical, Knoxville
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07817147

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • Sarah Cannon Research Institute (SCRI), Nashville
Тражи се учесникФаза 1
Узраст 19 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06586957

Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer

  • SCRI Oncology LLC, Nashville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06824064

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Sarah Cannon Research Institute SCRI, Nashville
  • Nashville General Hospital, Nashville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Sarah Cannon Research Institute, Nashville
  • Tennessee Oncology PLLC, Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Vanderbilt University Medical Center, Nashville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Tennessee Oncology Chattanooga, Chattanooga
  • University of Tennessee Medical Center, Knoxville
  • Baptist Memorial Hospital-Memphis, Memphis
  • и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • Sarah Cannon and HCA Research Institute, Nashville
  • Tennessee Oncology, Nashville
  • Vanderbilt University Medical Center, Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05614739

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

  • West Cancer Center, Germantown
Тражи се учесникФаза 1/2
Узраст 18 и старији · Жене · Ажурирано 3. 11. 2026. · NCT04802759

A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

  • Sarah Cannon Research Institute - Pharmacy, Nashville
  • SCRI Oncology Partners, Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07903415

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  • University of Tennessee Medical Center, Knoxville
  • Henry-Joyce Cancer Clinic, Nashville
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06943755

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

  • Vanderbilt Breast Center at One Hundred Oaks, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05803382

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens

  • Vanderbilt University Medical Center, Nashville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06127407

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

  • Research Site, Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06835569

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  • University of Tennessee Medical Center, Knoxville
  • Vanderbilt-Ingram Cancer Center, Nashville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06769698

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • SCRI Oncology Partners, Nashville
  • Vanderbilt Medical Center, Nashville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT04657068

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
Тражи се учесникОпсервациона студија
2 Months · Оба пола · Ажурирано 22. 10. 2026. · NCT02474160

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

  • Tennessee Oncology PLLC, Nashville
Тражи се учесникФаза 1
Узраст од 18 до 99 · Оба пола · Ажурирано 20. 10. 2026. · NCT07403721

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

  • Vanderbilt Breast Center at One Hundred Oaks, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06311214

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

  • SCRI Oncology Partners, Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06521554

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

  • Research Site, Nashville
Тражи се учесникФаза 3
Узраст од 18 до 130 · Оба пола · Ажурирано 19. 10. 2026. · NCT07647328

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Henry-Joyce Cancer Clinic, Nashville
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06989437

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Vanderbilt University Medical Center, Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT05382559

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

  • The West Clinic, PLLC dba West Cancer Center ( Site 0005), Germantown
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06863272

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  • Tennessee Oncology, PLLC- Chattanooga Downtown, Chattanooga
  • Tennessee Oncology, PLLC - Chattanooga Med Park II, Chattanooga
  • Tennessee Oncology, PLLC - Chattanooga Memorial, Chattanooga
  • и још 22
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07227415

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Tennessee Oncology, PLLC - Chattanooga Downtown, Chattanooga
  • Tennessee Oncology, PLLC - Chattanooga - Medical Park II, Chattanooga
  • Tennessee Oncology, PLLC - Franklin, Franklin
  • и још 11
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222566

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Henry-Joyce Cancer Clinic, Nashville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222800

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Sarah Cannon Research Institute, Nashville
  • SCRI Oncology Partners, Nashville
  • Tennessee Oncology, Nashville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07218380

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Sarah Cannon Research Institute, Nashville
  • Vanderbilt Ingram Cancer Center, Nashville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

  • Avenzo Therapeutics Recruiting Site, Nashville
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT07193511

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

  • Sarah Cannon Research Institute (SCRI), Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT06234605

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Sarah Cannon Research Institute, Nashville
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • SCRI Oncology Partners, Nashville
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06625775

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.